Goodbye CPAP? New sleep apnea pill cuts breathing events by 44%
Tuesday, September 1, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
A once-nightly pill cut breathing interruptions by about 44% in a major phase 3 sleep apnea trial, while improving oxygen levels and disease severity. By strengthening the muscles that keep the airway open during sleep, AD109 could offer a new option for people unable to tolerate CPAP. (via Science Daily)
Read the Full StoryThis article will expire in 24 days.
In the News...
View All Recent News
- Scientists find a weak spot in one of the deadliest brain cancers
- Some joints may be primed for rheumatoid arthritis before birth
- Heart disease and kidney disease can fuel each other. New guidelines aim to break the cycle
- Compound in blueberries may help muscle cells burn excess fat
- New injectable treatment helps the brain rebuild after stroke
- Stanford scientists discover a seafood that can reverse signs of aging
- Scientists reveal the hidden instructions that build the human brain
- A longer exhale may push your brain toward bolder decisions
- Bats carry dangerous viruses without getting sick. This may be why
- One immune switch may help drive aging across the body
- ADHD may have a surprising creative advantage
- Each extra hour of prolonged sitting linked to 9% higher cancer death risk
- Alzheimer’s may leave a mark on the brain long before plaques appear
- Money problems may age your brain faster
- “Broken heart syndrome” can look just like a heart attack. This test can tell them apart
- Your neighborhood in your 20s may shape your heart decades later
- Obesity leaves a lasting memory in immune cells
- Too much coffee may weaken bones, study finds
- High blood sugar may help cancer cells hide from the immune system
- Reaching 90 without dementia doesn’t mean you’re in the clear